10-Q Filing

CVS HEALTH CORP CIK: 64803 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0000064803-23-000016`
Period End Date	20230331
Filing Date	20230503
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	cvs-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 44 Cash Flow Statement 76 Stockholders Equity 32 Comprehensive Income 18

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.95B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.62B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.10B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.78B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$28.33B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$27.28B	USD	Point-in-time
Inventories	`InventoryNet`	$19.09B	USD	Point-in-time
Inventories	`InventoryNet`	$18.26B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$625.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$908.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.64B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.77B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$65.63B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$68.71B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.28B	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	458.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$21.61B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$21.10B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	480.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.87B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.87B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.66B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.87B	USD	Point-in-time
Goodwill	`Goodwill`	$84.06B	USD	Point-in-time
Goodwill	`Goodwill`	$78.15B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.80B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$26.37B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.23B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.23B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.82B	USD	Point-in-time
Total assets	`Assets`	$228.28B	USD	Point-in-time
Total assets	`Assets`	$239.33B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$12.53B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$14.84B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$19.42B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$20.05B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.89B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.14B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.50B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.43B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$21.52B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$18.75B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$4.97B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.09B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.68B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.68B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.78B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.78B	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$213.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$228.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.42B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$75.05B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.80B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.57B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$56.45B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$50.48B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.02B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$5.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.23B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.23B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.67B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.68B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.83B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.67B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$167.75B	USD	Point-in-time
Total liabilities	`Liabilities`	$156.51B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,759 shares issued and 1,279 shares outstanding at March 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.19B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,759 shares issued and 1,279 shares outstanding at March 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.31B	USD	Point-in-time
Treasury stock, at cost: 480 shares at March 31, 2023 and 458 shares at December 31, 2022	`TreasuryStockValue`	$31.86B	USD	Point-in-time
Treasury stock, at cost: 480 shares at March 31, 2023 and 458 shares at December 31, 2022	`TreasuryStockValue`	$33.80B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$56.40B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$57.75B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.26B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-875.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$71.47B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$71.38B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$300.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$198.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$228.28B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$239.33B	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$21.63B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$24.35B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$334.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$168.00M	USD	1 Quarter
Total revenues	`Revenues`	$76.83B	USD	1 Quarter
Total revenues	`Revenues`	$85.28B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$51.45B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$45.51B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$20.45B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$17.92B	USD	1 Quarter
Opioid litigation charge	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Opioid litigation charge	`GainLossRelatedToLitigationSettlement`	$-484.00M	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$349.00M	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$41.00M	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.58B	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.32B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$73.28B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$81.83B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.45B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.54B	USD	1 Quarter
Interest expense	`InterestExpense`	$586.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$589.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$22.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$42.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.00B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.88B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$646.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$737.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.14B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.35B	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.79	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.66	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.65	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.77	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.28B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.29B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.60	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.55	USD	1 Quarter

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$74.19B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$87.80B	USD	1 Quarter
Cash paid for prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$50.22B	USD	1 Quarter
Cash paid for prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$44.37B	USD	1 Quarter
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$16.62B	USD	1 Quarter
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$19.76B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$9.96B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.97B	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$426.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$199.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$782.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$773.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$75.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$96.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.44B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.56B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.89B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.57B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.47B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$2.36B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.05B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$984.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.09B	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-31.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$31.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.51B	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.99B	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.95B	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$362.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$14.00M	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.02B	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$779.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$722.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$297.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$96.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$34.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$62.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-128.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-149.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.73B	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.65B	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.65B	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.08B	USD	1 Quarter
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.96B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.61B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.96B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.61B	USD	Point-in-time
Net income	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income	`ProfitLoss`	$2.14B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.05B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.00B	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$89.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$103.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$-175.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$155.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.97B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$751.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$400.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-828.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.25B	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$348.00M	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.20B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.97B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$4.38B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$1.43B	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.04B	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-444.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.44B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.56B	USD	1 Quarter

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.14B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-763.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$389.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$300.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$122.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.97B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.96B	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$730.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$781.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-99.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time

Comprehensive Income 18 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income	`ProfitLoss`	$2.14B	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$470.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.13B	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-74.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$369.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-6.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-763.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$389.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.53B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.59B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.52B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.59B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.